AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (October 4, 2001). doi:10.1152/ajpheart.00767.2001
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/2/H766    most recent
00767.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reffelmann, T.
Right arrow Articles by Kloner, R. A
Right arrow Search for Related Content
PubMed
Right arrow Articles by Reffelmann, T.
Right arrow Articles by Kloner, R. A

Articles in PresS, published online ahead of print October 4, 2001
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00767.2001
Submitted on August 27, 2001
Accepted on September 26, 2001

Relationship Between No-Reflow and Infarct Size as Influenced by Different Durations of Ischemia and Reperfusion

Thorsten Reffelmann1, Sharon L Hale1, Guohu Li1, and Robert A Kloner1*

1 University of Southern California, The Heart Institute, Good Samaritan Hospital, Los Angeles, California, USA

* To whom correspondence should be addressed. E-mail: ThorstenReffelmann{at}web.de.

No-reflow after acute myocardial infarction is an important predictor of infarct size and clinical outcome. However, the exact relationship between no-reflow and infarct size remains to be determined, in particular as no-reflow may progress during the time course of reperfusion. Control groups of five previous protocols, using the anesthetized, open-chest rabbit model of coronary artery occlusion and reperfusion, were retrospectively analyzed with respect to the correlation between regional myocardial blood flow (RMBF, radioactive microspheres) and infarct size (triphenyltetrazolium chloride) in the course of reperfusion. After 30 minutes of occlusion, reflow (defined as the ratio of RMBF in the risk area divided by the non-ischemic area) declined from hyperemic values after 30 minutes of reperfusion (1.33 ± 0.81, RMBF in the risk area at the same time point: 2.25 ± 1.04 ml/g/min), to 0.47 ± 0.22 after 120 minutes, and 0.46 ± 0.13 after 180 minutes of reperfusion. After 120 minutes of ischemia, reflow at 30 minutes of reperfusion was 0.49 ± 0.24, and deteriorated by 120 minutes of reperfusion (0.26 ± 0.15). In every group, there was a strong correlation between infarct size and reflow (correlation coefficients: -0.62 to -0.82). The lines of regression for the groups with assessment of RMBF after 120 or 180 minutes of reperfusion were nearly identical regardless of the duration of ischemia. Thus, microvascular reperfusion injury led to a striking decrease in RMBF within the first two hours of reperfusion with infarct size as the major determinant of reflow at a given time point of reperfusion.




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. Francone, C. Bucciarelli-Ducci, I. Carbone, E. Canali, R. Scardala, F. A. Calabrese, G. Sardella, M. Mancone, C. Catalano, F. Fedele, et al.
Impact of Primary Coronary Angioplasty Delay on Myocardial Salvage, Infarct Size, and Microvascular Damage in Patients With ST-Segment Elevation Myocardial Infarction: Insight From Cardiovascular Magnetic Resonance
J. Am. Coll. Cardiol., December 1, 2009; 54(23): 2145 - 2153.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. L. Strande, M. E. Widlansky, N. E. Tsopanoglou, J. Su, J. Wang, A. Hsu, K. V. Routhu, and J. E. Baker
Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury
Cardiovasc Res, July 15, 2009; 83(2): 325 - 334.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Napodano, A. Ramondo, G. Tarantini, D. Peluso, S. Compagno, C. Fraccaro, A. C. Frigo, R. Razzolini, and S. Iliceto
Predictors and time-related impact of distal embolization during primary angioplasty
Eur. Heart J., February 1, 2009; 30(3): 305 - 313.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. G. Leshnower, H. Sakamoto, H. Hamamoto, A. Zeeshan, J. H. Gorman III, and R. C. Gorman
Progression of myocardial injury during coronary occlusion in the collateral-deficient heart: a non-wavefront phenomenon
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1799 - H1804.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Thibault, L. Gomez, E. Donal, G. Pontier, M. Scherrer-Crosbie, M. Ovize, and G. Derumeaux
Acute myocardial infarction in mice: assessment of transmurality by strain rate imaging
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H496 - H502.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. A. Burmeister, C. Rempf, T. G. Standl, S. Rehberg, S. Bartsch-Zwemke, T. Krause, S. Tuszynski, A. Gottschalk, and J. Schulte am Esch
Effects of prophylactic or therapeutic application of bovine haemoglobin HBOC-200 on ischaemia-reperfusion injury following acute coronary ligature in rats
Br. J. Anaesth., December 1, 2005; 95(6): 737 - 745.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
T. Reffemann and R. A. Kloner
Microvascular Alterations After Temporary Coronary Artery Occlusion: The No-Reflow Phenomenon
Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 163 - 172.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
E. Biagini, T. W. Galema, A. F. L. Schinkel, W. B. Vletter, J. R. T. C. Roelandt, and F. J. Ten Cate
Myocardial wall thickness predicts recovery of contractile function after primary coronary intervention for acute myocardial infarction
J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1489 - 1493.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. T Dirksen, G. Laarman, A. W.J van 't Hof, G. Guagliumi, W. A.L Tonino, L. Tavazzi, D. J.G.M Duncker, M. L Simoons, and on behalf of the PARI-MI Investigators
The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty: Safety and efficacy of a novel tetrapeptide, ITF-1697
Eur. Heart J., March 1, 2004; 25(5): 392 - 400.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Reffelmann and R. A. Kloner
Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage?
Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1134 - H1141.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Reffelmann and R. A. Kloner
Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1099 - H1107.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.